TY - JOUR
T1 - Unusually high concentrations of cTnI and cTnT in a patient with catastrophic antiphospholipid antibody syndrome
AU - Laterza, Omar F.
AU - Nayer, Hassan
AU - Jo Bill, Mary
AU - Sokoll, Lori J.
PY - 2003/11
Y1 - 2003/11
N2 - Background: We present a case of a patient with catastrophic antiphospholipid antibody syndrome with unusually high concentrations of cardiac Troponin I (cTnI) and cardiac Troponin T (cTnT). Troponins are sensitive and specific markers of myocardial injury. The degree of their elevation, in the context of the chronic autoimmune condition of the patient, elicited a thorough investigation for the presence of interfering antibodies. Methods: Cardiac markers, including total CK, CK-MB, cTnI, and cTnT, were measured in this patient over a period of 14 days after the onset of symptoms. In order to rule out a possible interference, serum samples were subjected to serial dilutions and were incubated with a blocking reagent (HBR) prior to analysis. Results: The time release of the cardiac markers into the systemic circulation of this patient followed the typical pattern after a myocardial infraction. Serial dilutions of the samples, and incubation with the blocking reagent revealed no indication of the presence of interfering antibodies. Conclusions: The results strongly suggest that the extremely high concentrations of cTnT and cTnI in this patient were real and indicative of a massive myocardial infarction (MI). These may be the highest concentrations of cTnI and cTnT reported in the systemic circulation of a single patient.
AB - Background: We present a case of a patient with catastrophic antiphospholipid antibody syndrome with unusually high concentrations of cardiac Troponin I (cTnI) and cardiac Troponin T (cTnT). Troponins are sensitive and specific markers of myocardial injury. The degree of their elevation, in the context of the chronic autoimmune condition of the patient, elicited a thorough investigation for the presence of interfering antibodies. Methods: Cardiac markers, including total CK, CK-MB, cTnI, and cTnT, were measured in this patient over a period of 14 days after the onset of symptoms. In order to rule out a possible interference, serum samples were subjected to serial dilutions and were incubated with a blocking reagent (HBR) prior to analysis. Results: The time release of the cardiac markers into the systemic circulation of this patient followed the typical pattern after a myocardial infraction. Serial dilutions of the samples, and incubation with the blocking reagent revealed no indication of the presence of interfering antibodies. Conclusions: The results strongly suggest that the extremely high concentrations of cTnT and cTnI in this patient were real and indicative of a massive myocardial infarction (MI). These may be the highest concentrations of cTnI and cTnT reported in the systemic circulation of a single patient.
KW - Antiphospholipid syndrome
KW - Cardiac troponin I
KW - Cardiac troponin T
KW - Case report
UR - http://www.scopus.com/inward/record.url?scp=0142195898&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0142195898&partnerID=8YFLogxK
U2 - 10.1016/j.cccn.2003.08.003
DO - 10.1016/j.cccn.2003.08.003
M3 - Article
C2 - 14568196
AN - SCOPUS:0142195898
SN - 0009-8981
VL - 337
SP - 173
EP - 176
JO - Clinica Chimica Acta
JF - Clinica Chimica Acta
IS - 1-2
ER -